Panadol Advance

Panadol is a globally recognised brand of paracetamol-based medication, originally developed as a safer alternative to aspirin. The Advance formula is specifically designed for faster absorption into the bloodstream. Panadol was first released by Frederick Stearns & Co in the 1950s before becoming a cornerstone of the Sterling Drug portfolio.

Today, the brand belongs to Haleon, a leading consumer healthcare company that was formed following the demerger of the consumer healthcare business from GSK (GlaxoSmithKline). Production is distributed across various global facilities, including major plants in the United Kingdom, Ireland, and Australia, to supply regional markets. As a household name in over 85 countries, it remains one of the most widely used over-the-counter pain relief brands worldwide.